Sequencing Screening Method Investigated for Childhood Cancer Precision Medicine Treatments
A key insight of this study is how comprehensive genomic sequencing (CGS) provided a detailed perspective of the genetic makeup of each patient’s tumor.
Oncology and Cancer Care
Newly Planned UC Davis Health Clinic Demonstrates the Growing Value of Theranostics
The field of theranostics is growing as a way to simultaneously diagnose and treat cancer, and plans at UC Davis Health reflect the potential value of this approach.
Hospitals Could Provide Safer, More Effective Cancer Radiation Treatments by Adjusting Them to Patients’ Genetics
A study of 1,600 cancer patients illustrates the potential benefits of using genomic-adjusted radiation dosing, or GARD, which oncologists can tailor to patients’ genetic risk factors.
New Biochip Provides a Variety of Cancer Benefits by Working With a Patient’s Immune System
New personalized biochip technology developed by Rensselaer Polytechnic Institute allows oncologists to test hundreds of treatment options at one time.
New Method of Eye Cancer Testing Provides Opportunity for Precision Medicine Breakthrough
One of the key findings of the Stanford Medicine research was that evaluating certain proteins better predicted the risk of metastasis of uveal melanoma when compared to conventional evaluation methods.
Australia Considers Making Low-Cost DNA Screen for Hereditary Cancers Widely Available
Some say clinical guidelines for detecting risk are too narrow and miss many at-risk individuals. Such testing may start people on the path to managing risk.
Single Cancer Vaccine or Set of Vaccines May Soon Cover Patient-Specific Mutations
Hospital leaders and oncologists should be aware of how cancer vaccine technology is developing and how it will be used to treat patient-specific tumors.
Blood Testing Technology May Yield Better Information Than Tissue Biopsies for Cancer
A recent Georgetown cfDNA analysis study points to certain modifications to DNA, called methylations, that allow researchers to identify what type of cell the DNA came from. The review may set the stage for future research efforts.
Israeli Researchers Use 3D Bio-Printing to Determine Best Precision Medicine Cancer Treatments
A new 3D bio-printing method marks an exciting beginning to precision medicine treatments for highly-aggressive glioblastoma cancer.
Massachusetts General Hospital Sees Success With AI-Based Precision Medicine Breast Cancer Screening
Breast imagers are uniquely positioned to lead the way in AI cancer screening through their extensive experience with computer-assisted diagnosis (CAD), stated Constance Lehman, MD, PhD, a diagnostic radiologist, Professor of Radiology at Harvard Medical School, and Director of Breast Imaging at MGH.